Oral Anticoagulation for Acute Coronary Syndromes

This publication has 25 references indexed in Scilit:

• Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina
  Journal of the American College of Cardiology, 2001
• Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial
  The Lancet, 1999
• Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction
  New England Journal of Medicine, 1997
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
  New England Journal of Medicine, 1996
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  BMJ, 1994
• Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study
  The Lancet, 1993
• Oral Anticoagulant Drugs
  New England Journal of Medicine, 1991
• The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
  New England Journal of Medicine, 1990
• Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole
  The American Journal of Cardiology, 1983